Viatris Inc (VTRS)

Mar 30, 2025

Viatris Inc. (VTRS): Among the Oversold Stocks to Buy in 2025 Amid Inflation Fears - Insider Monkey

Mar 30, 2025

Mar 30, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viatris Inc.VTRS - TradingView

Mar 30, 2025

Mar 30, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - GlobeNewswire Inc.

Mar 30, 2025

Mar 29, 2025

Lost Money on Viatris Inc.(VTRS)? You May Have Been Affected by Fraud- Contact Levi & Korsinsky - ACCESS Newswire

Mar 29, 2025

Mar 29, 2025

VTRS Investor News: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action InvestigationVTRS - PR Newswire

Mar 29, 2025

Mar 28, 2025

Viatris Inc. (VTRS) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire

Mar 28, 2025

Mar 28, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - PR Newswire

Mar 28, 2025

Mar 28, 2025

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025 - The Malaysian Reserve

Mar 28, 2025

Mar 28, 2025

Viatris to Report First Quarter 2025 Financial Results on May 8, 2025 – Company Announcement - Financial Times

Mar 28, 2025

Mar 27, 2025

Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible - GlobeNewswire

Mar 27, 2025

Mar 27, 2025

Viatris Inc. Announcement: If You Have Suffered Losses in Viatris Inc. (NASDAQ: VTRS), You Are - Bluefield Daily Telegraph

Mar 27, 2025

Mar 27, 2025

Viatris Inc. Announcement: If You Have Suffered Losses in - GlobeNewswire

Mar 27, 2025

Mar 27, 2025

The Global Market for Paclitaxel Injections Presents an - GlobeNewswire

Mar 27, 2025

Mar 26, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris – VTRS - GlobeNewswire

Mar 26, 2025

Mar 25, 2025

The Human Factor: Device Stress Tests Run Gamut to Mimic Real-World Use - Viatris

Mar 25, 2025

Mar 25, 2025

Viatris Inc. stock falls Tuesday, underperforms market - MarketWatch

Mar 25, 2025

Mar 25, 2025

Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of Manufacturing Facility – Hagens Berman - TradingView

Mar 25, 2025

Mar 25, 2025

Is Viatris Inc. (NASDAQ:VTRS) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Insider Monkey

Mar 25, 2025

Mar 22, 2025

Viatris Inc. Being Investigated on Behalf of Viatris Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire

Mar 22, 2025

Mar 21, 2025

VTRS Stock Quote - richtv.io

Mar 21, 2025

Mar 21, 2025

Viatris Inc. stock falls Friday, underperforms market - MarketWatch

Mar 21, 2025

Mar 21, 2025

Viatris Inc. (VTRS) Faces Investor Scrutiny After Possible Disclosure Delay About June 2024 FDA Inspection of - EIN News

Mar 21, 2025

Mar 21, 2025

Viatris Inc. INVESTIGATION: Levi & Korsinsky Investigates Potential Securities Fraud by Viatris Inc. (VTRS) - ACCESS Newswire

Mar 21, 2025

Mar 20, 2025

Did Viatris Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky InvestigateVTRS - ACCESS Newswire

Mar 20, 2025

Mar 18, 2025

VTRS Investigation: Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action InvestigationVTRS - PR Newswire

Mar 18, 2025

Mar 18, 2025

Viatris Inc. Announces Quarterly Dividend, Payable on March 18, 2025 -February 27, 2025 at 06:30 am EST - Marketscreener.com

Mar 18, 2025

Mar 17, 2025

Is Viatris Inc. (VTRS) the Best Nasdaq Stock Under $20 to Buy Now? - MSN

Mar 17, 2025

Mar 17, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - StreetInsider.com

Mar 17, 2025

Mar 17, 2025

Opus, Viatris Unit Sue Sandoz to Block Copy of Ryzumvi Eye Drug - Bloomberg Law

Mar 17, 2025

Mar 16, 2025

Viatris Inc. Under Investor Scrutiny: Levi & Korsinsky Launches Securities Investigation - Apna Kal

Mar 16, 2025

Mar 15, 2025

Viatris Stock Plummets Over 15% Amid Earnings Miss and FDA Warning – Investors Encouraged to Take Action - Apna Kal

Mar 15, 2025

Mar 14, 2025

Rosen Law Firm Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation – VTRS - Bluefield Daily Telegraph

Mar 14, 2025

Mar 14, 2025

Viatris Inc (VTRS) Volatility Hits 3.27% – Here Is What You Should Do - Stocks Register

Mar 14, 2025

Mar 14, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Viatris Inc. (VTRS) And Encourages Shareholders to Reach Out - Markets Insider

Mar 14, 2025

Mar 13, 2025

Investors who Lost Money on Viatris Inc. Should Contact Levi & Korsinsky About an Ongoing InvestigationVTRS - ACCESS Newswire

Mar 13, 2025

Mar 13, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Viatris Inc. (VTRS) and Encourages Shareholders to Learn More About the Investigation - Markets Insider

Mar 13, 2025

Mar 13, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Viatris - PR Newswire

Mar 13, 2025

Mar 12, 2025

Viatris Inc. (VTRS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider

Mar 12, 2025

Mar 12, 2025

Viatris Inc. (VTRS) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire

Mar 12, 2025

Mar 12, 2025

Viatris’s SWOT analysis: generic drug maker’s stock faces headwinds - Investing.com

Mar 12, 2025